Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found that tens of thousands of Americans have ended up in the emergency room from ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

For example, a 2021 Wegovy trial with almost ... There are a few different semaglutide drugs. Here’s a quick rundown: Wegovy. Wegovy is a weekly injection FDA-approved for those with excess ...

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing. But experts have concerns.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

NO doubt you’ve heard the warnings. Drugs come with side effects – often unpleasant, dangerous, in rare cases ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The drug, semaglutide, belongs to a class of medicines ... The drug resmetirom, for example, helped improve liver scarring in a late-stage trial published last year and has since been green ...